{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:37Z","timestamp":1762876057643,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373071"],"award-info":[{"award-number":["81373071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Project for Anhui Province Academic Technology Leader Reserve Candidates\u2019 Academic Research Activities","award":["2017H108"],"award-info":[{"award-number":["2017H108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40618-018-0968-z","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T12:43:11Z","timestamp":1541076191000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association of benign thyroid diseases with thyroid cancer risk: a meta-analysis of prospective observational studies"],"prefix":"10.1007","volume":"42","author":[{"given":"L.","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-C.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2127-3668","authenticated-orcid":false,"given":"F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"issue":"1","key":"968_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. CA Cancer J Clin 68(1):7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"key":"968_CR2","doi-asserted-by":"publisher","first-page":"965212","DOI":"10.1155\/2013\/965212","volume":"2013","author":"G Pellegriti","year":"2013","unstructured":"Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212. \n                    https:\/\/doi.org\/10.1155\/2013\/965212","journal-title":"J Cancer Epidemiol"},{"issue":"5","key":"968_CR3","doi-asserted-by":"publisher","first-page":"E911","DOI":"10.3390\/ijms18050911","volume":"18","author":"E Albi","year":"2017","unstructured":"Albi E, Cataldi S, Lazzarini A, Codini M, Beccari T, Ambesi-Impiombato FS, Curcio F (2017) Radiation and thyroid cancer. Int J Mol Sci 18(5):E911. \n                    https:\/\/doi.org\/10.3390\/ijms18050911","journal-title":"Int J Mol Sci"},{"issue":"1","key":"968_CR4","first-page":"1","volume":"79","author":"E Ron","year":"1987","unstructured":"Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr (1987) A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79(1):1\u201312","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"968_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/ije\/18.3.578","volume":"18","author":"S Franceschi","year":"1989","unstructured":"Franceschi S, Fassina A, Talamini R, Mazzolini A, Vianello S, Bidoli E, Serraino D, La Vecchia C (1989) Risk factors for thyroid cancer in northern Italy. Int J Epidemiol 18(3):578\u2013584","journal-title":"Int J Epidemiol"},{"key":"968_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2017.10.006","author":"PY Ren","year":"2017","unstructured":"Ren PY, Liu J, Xue S, Chen G (2017) Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto\u2019s thyroiditis. Asian J Surg. \n                    https:\/\/doi.org\/10.1016\/j.asjsur.2017.10.006","journal-title":"Asian J Surg"},{"issue":"3","key":"968_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s12020-018-1523-6","volume":"59","author":"AA Tam","year":"2018","unstructured":"Tam AA, Ozdemir D, Ayd\u0131n C, Bestepe N, Ulusoy S, Sungu N, Ersoy R, Cakir B (2018) Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer. Endocrine 59(3):565\u2013572. \n                    https:\/\/doi.org\/10.1007\/s12020-018-1523-6","journal-title":"Endocrine"},{"issue":"1","key":"968_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jcph.972","volume":"58","author":"SH Hung","year":"2018","unstructured":"Hung SH, Chung SD, Lin HC (2018) Thyroxin use is associated with increased risk of thyroid cancer in patients with hypothyroidism. J Clin Pharmacol 58(1):29\u201333. \n                    https:\/\/doi.org\/10.1002\/jcph.972","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"968_CR9","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1210\/jc.2017-02599","volume":"103","author":"CM Kitahara","year":"2018","unstructured":"Kitahara CM, Farkas DK, J\u00f8rgensen JOL, Cronin-Fenton D, S\u00f8rensen HT (2018) Benign thyroid diseases and risk of thyroid cancer: a nationwide cohort study. J Clin Endocrinol Metab 103(6):2216\u20132224. \n                    https:\/\/doi.org\/10.1210\/jc.2017-02599","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"968_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/thy.2009.0450","volume":"20","author":"C Anil","year":"2010","unstructured":"Anil C, Goksel S, Gursoy A (2010) Hashimoto\u2019s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20(6):601\u2013606. \n                    https:\/\/doi.org\/10.1089\/thy.2009.0450","journal-title":"Thyroid"},{"issue":"1","key":"968_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5603\/EP.a2016.0022","volume":"67","author":"F Gabalec","year":"2016","unstructured":"Gabalec F, Srbova L, Nova M, Hovorkova E, Hornychova H, Jakubikova I, Ryska A, Cap J (2016) Impact of Hashimoto\u2019s thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence. Endokrynol Polska 67(1):48\u201353. \n                    https:\/\/doi.org\/10.5603\/EP.a2016.0022","journal-title":"Endokrynol Polska"},{"issue":"3","key":"968_CR12","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00405-016-4414-6","volume":"274","author":"A Selek","year":"2017","unstructured":"Selek A, Cetinarslan B, Tarkun I, Canturk Z, Ustuner B, Akyay Z (2017) Thyroid autoimmunity: is really associated with papillary thyroid carcinoma? Eur Arch Otorhinolaryngol 274(3):1677\u20131681. \n                    https:\/\/doi.org\/10.1007\/s00405-016-4414-6","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"968_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1023\/A:1008907227706","volume":"10","author":"S Franceschi","year":"1999","unstructured":"Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, McTiernan A, Kolonel L, Mark SD, Mabuchi K, Jin F, Wingren G, Galanti R, Hallquist A, Glattre E, Lund E, Levi F, Linos D, Ron E (1999) A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 10(6):583\u2013595","journal-title":"Cancer Causes Control"},{"key":"968_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijsu.2015.11.027","volume":"27","author":"JU Staniforth","year":"2016","unstructured":"Staniforth JU, Erdirimanne S, Eslick GD (2016) Thyroid carcinoma in Graves\u2019 disease: a meta-analysis. Int J Surg 27:118\u2013125. \n                    https:\/\/doi.org\/10.1016\/j.ijsu.2015.11.027","journal-title":"Int J Surg"},{"issue":"37","key":"968_CR15","doi-asserted-by":"publisher","first-page":"62414","DOI":"10.18632\/oncotarget.18620","volume":"8","author":"X Lai","year":"2017","unstructured":"Lai X, Xia Y, Zhang B, Li J, Jiang Y (2017) A meta-analysis of Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma risk. Oncotarget 8(37):62414\u201362424. \n                    https:\/\/doi.org\/10.18632\/oncotarget.18620","journal-title":"Oncotarget"},{"key":"968_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2017.00053","volume":"7","author":"C Resende de Paiva","year":"2017","unstructured":"Resende de Paiva C, Gr\u00f8nh\u00f8j C, Feldt-Rasmussen U, von Buchwald C (2017) Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients. Front Oncol 7:53. \n                    https:\/\/doi.org\/10.3389\/fonc.2017.00053","journal-title":"Front Oncol"},{"issue":"15","key":"968_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"issue":"11","key":"968_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"7109","key":"968_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"8","key":"968_CR20","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1210\/jc.2011-2996","volume":"97","author":"S Balasubramaniam","year":"2012","unstructured":"Balasubramaniam S, Ron E, Gridley G, Schneider AB, Brenner AV (2012) Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million US male veterans. J Clin Endocrinol Metab 97(8):2661\u20132669. \n                    https:\/\/doi.org\/10.1210\/jc.2011-2996","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"968_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ijc.1377","volume":"93","author":"C Iribarren","year":"2001","unstructured":"Iribarren C, Haselkorn T, Tekawa IS, Friedman GD (2001) Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 93(5):745\u2013750","journal-title":"Int J Cancer"},{"issue":"2","key":"968_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/kwp354","volume":"171","author":"CL Meinhold","year":"2010","unstructured":"Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS, Berrington de Gonz\u00e1lez A (2010) Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. Am J Epidemiol 171(2):242\u2013252. \n                    https:\/\/doi.org\/10.1093\/aje\/kwp354","journal-title":"Am J Epidemiol"},{"issue":"6","key":"968_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1667\/RR2181.1","volume":"174","author":"MJ Adams","year":"2010","unstructured":"Adams MJ, Shore RE, Dozier A, Lipshultz SE, Schwartz RG, Constine LS, Pearson TA, Stovall M, Thevenet-Morrison K, Fisher SG (2010) Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort. Radiat Res 174(6):753\u2013762. \n                    https:\/\/doi.org\/10.1667\/RR2181.1","journal-title":"Radiat Res"},{"issue":"7","key":"968_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1055\/s-0033-1341474","volume":"121","author":"NC Yeh","year":"2013","unstructured":"Yeh NC, Chou CW, Weng SF, Yang CY, Yen FC, Lee SY, Wang JJ, Tien KJ (2013) Hyperthyroidism and thyroid cancer risk: a population-based cohort study. Exp Clin Endocrinol Diabetes 121(7):402\u2013406. \n                    https:\/\/doi.org\/10.1055\/s-0033-1341474","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"968_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2012.0568","volume":"23","author":"YK Chen","year":"2013","unstructured":"Chen YK, Lin CL, Chang YJ, Cheng FT, Peng CL, Sung FC, Cheng YH, Kao CH (2013) Cancer risk in patients with Graves\u2019 disease: a nationwide cohort study. Thyroid 23(7):879\u2013884. \n                    https:\/\/doi.org\/10.1089\/thy.2012.0568","journal-title":"Thyroid"},{"issue":"3","key":"968_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1245\/s10434-013-3363-1","volume":"21","author":"CL Liu","year":"2014","unstructured":"Liu CL, Cheng SP, Lin HW, Lai YL (2014) Risk of thyroid cancer in patients with thyroiditis: a population-based cohort study. Ann Surg Oncol 21(3):843\u2013849. \n                    https:\/\/doi.org\/10.1245\/s10434-013-3363-1","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"968_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJM198503073121001","volume":"312","author":"LE Holm","year":"1985","unstructured":"Holm LE, Blomgren H, L\u00f6whagen T (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312(10):601\u2013604","journal-title":"N Engl J Med"},{"issue":"9","key":"968_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.1998.8.751","volume":"8","author":"A Mellemgaard","year":"1998","unstructured":"Mellemgaard A, From G, J\u00f8rgensen T, Johansen C, Olsen JH, Perrild H (1998) Cancer risk in individuals with benign thyroid disorders. Thyroid 8(9):751\u2013754","journal-title":"Thyroid"},{"issue":"9","key":"968_CR29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/sj.bjc.6605624","volume":"102","author":"X Shu","year":"2010","unstructured":"Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk in patients hospitalised for Graves\u2019 disease: a population-based cohort study in Sweden. Br J Cancer 102(9):1397\u20131399. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6605624","journal-title":"Br J Cancer"},{"issue":"3","key":"968_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1967\/s002449910408","volume":"19","author":"SN Divani","year":"2016","unstructured":"Divani SN, Kalodimos GP, Lioupis MA, Syrmos NC (2016) Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value? Hell J Nucl Med 19(3):250\u2013253. \n                    https:\/\/doi.org\/10.1967\/s002449910408","journal-title":"Hell J Nucl Med"},{"issue":"4","key":"968_CR31","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1210\/jc.2015-3783","volume":"101","author":"Y Yu","year":"2016","unstructured":"Yu Y, Zhang J, Lu G, Li T, Zhang Y, Yu N, Gao Y, Gao Y, Guo X (2016) Clinical relationship between IgG4-positive Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma. J Clin Endocrinol Metab 101(4):1516\u20131524. \n                    https:\/\/doi.org\/10.1210\/jc.2015-3783","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"968_CR32","first-page":"171","volume":"2","author":"Z Moazezi","year":"2011","unstructured":"Moazezi Z, Mahmoudi M, Yahyahpour Y, Alaleh A (2011) Risk factors of thyroid cancer in Babol, Northern Iran. Casp J Intern Med 2(1):171\u2013177","journal-title":"Casp J Intern Med"},{"issue":"2","key":"968_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4158\/EP12234.OR","volume":"19","author":"R Negro","year":"2013","unstructured":"Negro R, Valcavi R, Toulis KA (2013) Incidental thyroid cancer in toxic and nontoxic goiter: is TSH associated with malignanCy rate? Results of a meta-analysis. Endocr Pract 19(2):212\u2013218. \n                    https:\/\/doi.org\/10.4158\/EP12234.OR","journal-title":"Endocr Pract"},{"issue":"1","key":"968_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1210\/edrv-9-1-106","volume":"9","author":"B Rees Smith","year":"1988","unstructured":"Rees Smith B, McLachlan SM, Furmaniak J (1988) Autoantibodies to the thyrotropin receptor. Endocr Rev 9(1):106\u2013121","journal-title":"Endocr Rev"},{"issue":"9","key":"968_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/BF03343633","volume":"22","author":"TM Valenti","year":"1999","unstructured":"Valenti TM, Macchia E, Pisa R, Bucalo ML, Russo V, Colletti I, Compagno V, Abbadi V, Donatelli M (1999) Toxic adenoma and papillary thyroid carcinoma in a patient with Graves\u2019 disease. J Endocrinol Investig 22(9):701\u2013704","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"968_CR36","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1210\/jcem-70-4-830","volume":"70","author":"A Belfiore","year":"1990","unstructured":"Belfiore A, Garofalo MR, Guiffrida D, Runello F, Filetti S, Fiumara A, Ippolito O, Vigneri R (1990) Increased aggressiveness of thyroid cancer in patients with Graves\u2019 disease. J Clin Endocrinol Metab 70(4):830\u2013835","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"968_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1210\/er.2009-0041","volume":"31","author":"GE Krassas","year":"2010","unstructured":"Krassas GE, Poppe K, Glinoer D (2010) Thyroid function and human reproductive health. Endocr Rev 31(5):702\u2013755. \n                    https:\/\/doi.org\/10.1210\/er.2009-0041","journal-title":"Endocr Rev"},{"issue":"5","key":"968_CR38","first-page":"1067","volume":"36","author":"A Kumar","year":"2010","unstructured":"Kumar A, Klinge CM, Goldstein RE (2010) Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors \u03b1 and \u03b2. Int J Oncol 36(5):1067\u20131080","journal-title":"Int J Oncol"},{"issue":"4","key":"968_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.280.4.347","volume":"280","author":"E Ron","year":"1998","unstructured":"Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS 3rd, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warschauer ME, Wong FL, Boice JD Jr (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280(4):347\u2013355","journal-title":"JAMA"},{"issue":"9170","key":"968_CR40","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/S0140-6736(98)12295-X","volume":"353","author":"JA Franklyn","year":"1999","unstructured":"Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P (1999) Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353(9170):2111\u20132115","journal-title":"Lancet"},{"issue":"9","key":"968_CR41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/thy.2008.0061","volume":"18","author":"J Jonklaas","year":"2008","unstructured":"Jonklaas J, Nsouli-Maktabi H, Soldin SJ (2008) Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18(9):943\u2013952. \n                    https:\/\/doi.org\/10.1089\/thy.2008.0061","journal-title":"Thyroid"},{"issue":"3","key":"968_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jc.2007-2215","volume":"93","author":"MR Haymart","year":"2008","unstructured":"Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H (2008) Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93(3):809\u2013814","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"968_CR43","doi-asserted-by":"publisher","first-page":"dju097","DOI":"10.1093\/jnci\/dju097","volume":"106","author":"S Rinaldi","year":"2014","unstructured":"Rinaldi S, Plummer M, Biessy C, Tsilidis KK, \u00d8stergaard JN, Overvad K, Tj\u00f8nneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quir\u00f3s JR, Agudo A, Molina E, Larra\u00f1aga N, Navarro C, Ardanaz E, Manjer J, Almquist M, Sandstr\u00f6m M, Hennings J, Khaw KT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, Gunter M, Riboli E, Franceschi S (2014) Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst 106(6):dju097","journal-title":"J Natl Cancer Inst"},{"issue":"30","key":"968_CR44","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.2174\/092986710792927804","volume":"17","author":"A Bozec","year":"2010","unstructured":"Bozec A, Lassalle S, Hofman V, Ilie M, Santini J, Hofman P (2010) The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. Curr Med Chem 17(30):3449\u20133461","journal-title":"Curr Med Chem"},{"issue":"5","key":"968_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","volume":"72","author":"M Muzza","year":"2010","unstructured":"Muzza M, Degl\u2019Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L (2010) The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72(5):702\u2013708. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03699.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"968_CR46","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00268-008-9484-1","volume":"32","author":"N Arora","year":"2008","unstructured":"Arora N, Scognamiglio T, Zhu B, Fahey TJ 3rd (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32(7):1237\u20131246. \n                    https:\/\/doi.org\/10.1007\/s00268-008-9484-1","journal-title":"World J Surg"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0968-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0968-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0968-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T06:34:19Z","timestamp":1572590059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0968-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0968-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"29 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Since this is a meta-analysis, informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}